Last reviewed: June 24, 2026
Last updated: June 24, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide injection—the active ingredient in Ozempic—works by slowing stomach emptying and signaling fullness to your brain, which causes its most common side effects. Most patients experience mild-to-moderate gastrointestinal discomfort in the first 2–4 weeks, but symptoms typically improve as your body adjusts. Understanding what to expect and how to manage these effects helps you stay on track with your weight loss journey.
Nausea and Vomiting: The Most Reported Semaglutide Side Effects
Nausea affects up to 40% of semaglutide users during early treatment weeks, making it the most frequently reported side effect. This occurs because GLP-1 agonists slow the rate at which your stomach empties food into the small intestine, triggering nausea signals in your brain's chemoreceptor trigger zone. Vomiting is less common, occurring in roughly 10–15% of patients, and usually develops only if nausea is unmanaged or dosing escalates too rapidly.
Most nausea peaks around days 3–7 after your first injection and gradually diminishes over 2–3 weeks as your digestive system adapts. Eating smaller, lower-fat meals; staying hydrated; and avoiding strong food odors can reduce symptoms. If nausea persists beyond four weeks or significantly impacts your quality of life, speak with your provider about dose adjustments—PlexusDx's personalized approach means your dose increases only when your body is ready, not on a fixed schedule.
Constipation and Gastrointestinal Changes During GLP-1 Therapy
Constipation is one of the longest-lasting side effects, affecting 20–30% of semaglutide users and sometimes persisting beyond the nausea phase. Because GLP-1 agonists slow stomach and intestinal motility, stool moves through your colon more slowly, leading to harder, less frequent bowel movements. Adequate fiber intake, increased water consumption (at least 8–10 glasses daily), and gentle movement like walking can naturally restore regularity without medication.
Diarrhea affects a smaller percentage (5–10%) of patients and typically occurs when dosing escalates too quickly or when diet changes introduce more fiber than your system can initially process. PlexusDx's genetic testing component, the Precision Peptide Genetic Test, can reveal individual variations in your peptide pathways—such as MC4R rs17782313 status—that may predict gastrointestinal tolerance and help your provider personalize your dosing timeline to minimize these effects.
Appetite Suppression, Fatigue, and Metabolic Adjustments
Appetite suppression is the intended therapeutic effect of semaglutide, but some patients experience it so strongly that eating becomes a conscious effort rather than a natural urge. This 'loss of appetite' sensation—distinct from nausea—typically begins within 24–48 hours and can last indefinitely while on medication. For most users, this is desirable and drives weight loss; however, insufficient caloric or protein intake can lead to muscle loss, nutritional deficiencies, and fatigue.
Fatigue during the first 1–2 weeks affects roughly 15–20% of users and usually stems from reduced food intake, dehydration, or your body's metabolic shift away from rapid glucose processing. Eating protein-rich foods at regular intervals, even when not hungry, and consulting a registered dietitian familiar with GLP-1 therapy can prevent malnutrition-related tiredness. PlexusDx providers work with you to establish sustainable eating patterns that maintain energy while maximizing weight loss benefits.
Managing Side Effects and When to Adjust Your Semaglutide Dose
The cornerstone of side effect management is gradual dose escalation—a strategy built into most semaglutide protocols but essential to discuss with your prescriber. PlexusDx's pricing model reflects this principle: your monthly cost remains flat regardless of dose level, because your dose may go up as your body adapts, but your price will not. This removes the financial pressure to accelerate dosing before you're physiologically ready and reduces the severity of adjustment symptoms.
If side effects become intolerable, several evidence-based strategies exist: reduce meal portion sizes and eat every 2–3 hours; take ginger supplements or use acupressure wristbands for nausea; use stool softeners or osmotic laxatives for constipation; and stay in close contact with your provider about timing adjustments. The Precision Peptide Genetic Test can also identify your genetic predisposition across 14 peptide pathways and 49 specific peptides, allowing PlexusDx to anticipate which side effects you're most likely to experience and adjust your protocol proactively rather than reactively.
How Long Do Ozempic Injection Side Effects Last?
Most acute gastrointestinal side effects—nausea, vomiting, and early appetite changes—resolve within 2–4 weeks as your body's GLP-1 receptors downregulate and your digestive tract adapts to slower motility. Constipation may persist longer, sometimes 4–8 weeks, particularly if dietary fiber and hydration are insufficient. Individual timelines vary significantly based on genetics, concurrent medications, diet, and starting dose—which is why personalized medicine approaches like PlexusDx's genetic testing component matter.
Rare but serious side effects, including severe pancreatitis or thyroid changes, have been documented in clinical trials and post-market surveillance; these typically emerge within the first few months and require immediate medical attention. Mild side effects like dry mouth or headache occasionally linger throughout treatment but rarely justify stopping therapy. If you experience persistent, severe, or unusual symptoms beyond 6 weeks, contact your PlexusDx provider immediately for dose review or medication alternatives.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Do all semaglutide injection users experience nausea and side effects?
No—approximately 20–30% of patients experience minimal to no gastrointestinal discomfort, while others report significant symptoms in the first weeks. Your genetic profile, starting dose, eating patterns, and rate of dose escalation all influence your individual side effect burden. PlexusDx's Precision Peptide Genetic Test examines variants in GLP1R rs6923761 and other key sites to help predict your likely response and personalize your protocol from the start.
Can I take anti-nausea medication alongside semaglutide injections?
Yes—over-the-counter options like ondansetron (Zofran), metoclopramide (Reglan), or ginger supplements are commonly used alongside semaglutide with your provider's approval. However, metoclopramide can interfere with semaglutide's gastric-slowing mechanism, so it's best discussed with your PlexusDx prescriber. Most patients find that slow, deliberate dose escalation prevents nausea severe enough to require additional medication.
Why does PlexusDx charge a flat monthly price instead of charging more for higher doses?
PlexusDx's flat-rate pricing model—starting at $149/month for compounded semaglutide injection—reflects the medical principle that dose increases are necessary adjustments, not premium upgrades. Your dose may go up as your body adapts, but your price will not, removing financial barriers to safe, gradual dose escalation and reducing the temptation to escalate faster than your system can tolerate.
Is constipation from semaglutide permanent, or does it resolve after stopping the medication?
Constipation typically resolves within 1–2 weeks after discontinuing semaglutide, as your digestive motility returns to baseline. However, maintaining increased water and fiber intake during treatment prevents the need to stop and restart, which disrupts weight loss momentum. PlexusDx providers help you establish sustainable bowel-support strategies to keep you on therapy and on track.
How does the Precision Peptide Genetic Test predict my side effect risk?
The Precision Peptide Genetic Test ($99 add-on after your first month) analyzes 14 metabolic pathways and 150+ genetic insights, including variants like FTO rs9939609 and MC4R rs17782313, which correlate with GLP-1 sensitivity and gastrointestinal tolerance. PlexusDx uses these results to recommend starting doses, escalation schedules, and alternative compounds (like tirzepatide) that may suit your biology better and reduce bothersome side effects.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How to Use the Ozempic Shot: A Step-by-Step Guide
What to Eat When Taking Wegovy for Weight Loss